The CDC recently released the first US evidence-based guidelines on pediatric mild traumatic brain injury. Scroll through our quick slideshow to get the highlights.
FDA Clears IND for CAR-T Cell Therapy Equecabtagene Autoleucel in Multiple Sclerosis
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Biogen and Sage Terminate Development of SAGE-324 Following Disappointing Phase 2 Data
Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease
FDA Clears IND Application for Myogenica’s MyoPAXon in Muscular Dystrophy
Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data